CDC Redacted Emails & More V-Safe Injury Reports & Adverse Events in VAERS Are in Predominantly Republican States

April 23, 2024

https://www.theepochtimes.com/us/covid-19-vaccine-emails-heres-what-the-cdc-hid-behind-redactions

COVID-19 Vaccine Emails: Here’s What the CDC Hid Behind Redactions

Public health agency rolled back some redactions after Epoch Times appeal

4/22/2024

The U.S. Centers for Disease Control and Prevention (CDC) hid how a woman who suffered chest pain and other symptoms following COVID-19 vaccination received a shot because of a mandate at work, newly obtained documents show.

The agency also redacted how multiple children were diagnosed with Kawasaki Disease after receiving a COVID-19 vaccine, according to the documents.

The Epoch Times obtained more than 1,400 pages of emails from the CDC concerning its Clinical Immunization Safety Assessment (CISA) project, which analyzes post-vaccination problems reported by health care providers. The tranche included numerous redactions.  (See link for article)
______________
Important note:
The CDC has portrayed multi-system inflammatory syndrome in children (MIS-C) as only being caused by COVID despite studies finding there were MIS-C cases before COVID and that some actually suffer with it after “vaccination.”
And, Kawasaki Disease was detected as a safety signal for the Pfizer and Moderna vaccines among children aged 5 to 11 in 2022, according to files previously obtained by The Epoch Times.
A lawyer at the Project On Government Oversight told senators in 2022 that the CDC often withholds records simply because they may reveal problems at the agency or ‘paint the agency in a bad light.’

https://www.theepochtimes.com/epochtv/after-2-year-legal-fight-cdc-releases-780k-vaccine-injury-reports-from-v-safe-system-facts-matter-exclusive  Approx. 11 Min

CDC Releases 780,000 ‘Vaccine’ Injury Reports from V-Safe System

4/11/24

After resisting legal challenges for 2 years, the CDC has finally begun to release tranches of vaccine injury data that came from the self-reporting V-safe system. Let’s go through the history of this legal battle, as well as what the data reveals.

V-Safe is an active surveillance program which began in 2020 to monitor the safety of COVID-19 ‘vaccines’ during the period when the ‘vaccines’ are authorized for use under the FDA’s Emergency Use Authorization and possibly early after ‘vaccine’ licensure.  It is a device “app” which requires online registration.

VAERS is an older way of collecting safety data which is passive, where one can fill out a form online or manually, or by calling a toll-free number.

For the past FOUR YEARS the CDC has been refusing to release the V-Safe data to the public.
Then they abruptly stopped collecting data on COVID ‘vaccine’ injuries in June of 2023.

The courts have stepped in on multiple occasions forcing the CDC to release the data.

  • The first time was in 2022 when a lawsuit forced the CDC to release a small portion of the data which showed that nearly 8% of the 10 million users required medical attention or hospital care after ‘vaccination, and many others reported missing school, work, or other normal activities.  
  • Then in 2023 a judged ordered the CDC to disclose free-text entries from a different section of the survey in which individuals could describe their experiences. The first two tranches, made up of 780,000 reports from some 523,000 people, included dozens of reports of heart inflammation, hundreds of reports of facial paralysis, and thousands of reports of tinnitus.
  • In Feb. and March of this year, more reports showed serious adverse events including loss of consciousness and seizures, suicidal ideation, hearing voices, inability to focus, confusion,
  • Despite myocarditis and heart issues being a known side-effect of the gene therapy injections, there was no slot for patients to check the box for this particular side-effect.  The only way they could record these events was through V-Safe text box.

The fact a lawsuit was required to compel access to the V-Safe data is a shameful chapter where public health officials attempt to cover up ‘vaccine’ risks by ignoring patterns of reaction symptoms in reports made to the government.

It’s impossible to know when officials knew about the side effects as the entries are not in any sort of chronological order.  This is quite convenient for culpable public health agencies.

What else are government officials hiding?

Freedom Coalition of Doctors for Choice is pushing to have the dates released.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2816958

Original Investigation
Public Health
March 29, 2024

Reports of COVID-19 Vaccine Adverse Events in Predominantly Republican vs Democratic States

David A. Asch, MD, MBA1,2; Chongliang Luo, PhD3; Yong Chen, PhD2,4,5
Author Affiliations Article Information
JAMA Netw Open. 2024;7(3):e244177. doi:10.1001/jamanetworkopen.2024.4177
Abstract

Importance  Anti-vaccine sentiment is increasingly associated with conservative political positions. Republican-inclined states exhibit lower COVID-19 vaccination rates, but the association between political inclination and reported vaccine adverse events (AEs) is unexplored.

Objective  To assess whether there is an association between state political inclination and the reporting rates of COVID-19 vaccine AEs.

Design, Setting, and Participants  This cross-sectional study used the AE reports after COVID-19 vaccination from the Vaccine Adverse Event Reporting System (VAERS) database from 2020 to 2022, with reports after influenza vaccines from 2019 to 2022 used as a reference. These reports were examined against state-level percentage of Republican votes in the 2020 US presidential election.

Exposure  State-level percentage of Republican votes in the 2020 US presidential election.

Main Outcomes and Measures  Rates of any AE among COVID-19 vaccine recipients, rates of any severe AE among vaccine recipients, and the proportion of AEs reported as severe.

Results  A total of 620, 456 AE reports (mean [SD] age of vaccine recipients, 51.8 [17.6] years; 435 797 reports from women [70.2%]; a vaccine recipient could potentially file more than 1 report, so reports are not necessarily from unique individuals) for COVID-19 vaccination were identified from the VAERS database. Significant associations between state political inclination and state AE reporting were observed for all 3 outcomes: a 10% increase in Republican voting was associated with increased odds of AE reports (odds ratio [OR], 1.05; 95% CI, 1.05-1.05; P < .001), severe AE reports (OR, 1.25; 95% CI, 1.24-1.26; P < .001), and the proportion of AEs reported as severe (OR, 1.21; 95% CI, 1.20-1.22; P < .001). These associations were seen across all age strata in stratified analyses and were more pronounced among older subpopulations.

Conclusions and Relevance  This cross-sectional study found that the more states were inclined to vote Republican, the more likely their vaccine recipients or their clinicians reported COVID-19 vaccine AEs. These results suggest that either the perception of vaccine AEs or the motivation to report them was associated with political inclination.

_____________

**Comment**

This correlation not found when they looked at the flu vaccine.

One could postulate that Red states were targeted with “hot” batches described to be used with ‘strategic intent’ not mishap or coincidence, that have been found to cause 100% of ‘vaccine’ deaths caused by just 5% of the batches.

Resources:

Category:

Activism, vaccines, Viruses

Comments Off on CDC Redacted Emails & More V-Safe Injury Reports & Adverse Events in VAERS Are in Predominantly Republican States

Leaked Dossier Shows German Government Conspired to Silence Reiner Fuëllmich

Many COVID truth-tellers have paid the ultimate price by having to face severe persecution that has come in many forms.  German attorney Reiner Fuëllmich is a perfect example.  He was arrested at the airport and is now in forced detention in Göttingen, Germany with no warm clothes, no private phone time, no computer to prepare his case and no freedom to even discuss it. 

Fuellmich has led the charge of an international investigation to uncover and expose the COVID ‘plandemic.’  GiveSendGo

https://gregreese.substack.com/p/leaked-dossier-shows-german-government  Video Here (Approx. 6 Min)

Leaked Dossier Shows German Government Conspired To Silence Reiner Fuëllmich

Accuser connected to German Intelligence and pedophile cover-up
 
GREG REESE
APR 11, 2024

An alleged leaked dossier shows that German intelligence agencies conspired to create a false construct in order to silence Reiner Fuëllmich, disqualify him from being able to run for public office, and seize control of the Corona committee and its finances…..

While some are claiming the dossier is a fake, the evidence already on record overwhelmingly shows that Fuëllmich was targeted by the German government for his far reaching voice exposing the crimes of the COVID lockdowns and mandated experimental shots…..

For more background on this case, see my report, the Illegal Kidnapping and Persecution of Reiner Fuëllmich.

Go here for an 18 minute recording from Fuellmich in prison where he reveals the deep infiltration, intelligence gathering and plot around the ‘COVID Empire of Lies Crumbling.’

Germany appears to be in the spotlight with the RKI Files showing yet more ‘pandemic’ fraud. The files show that politicians ordered the experts to make up stories and narratives so as to support the government’s preconceived measures.

But Germany is far from alone.

There has been a recent Dutch Government Data hack where millions of records have been seen showing a massive coverup by the government on the exploding excess deaths after the COVID gene therapy injections.

MP Andrew Bridgen spoke to an empty, bought-out Parliament about COVID shot excess deaths which he called the ‘Greatest Medical Scandal in the UK.‘ The public’s moving response in the gallery at the end says it all.

“I say to the House in all seriousness that this debate and others like it are going to be pored over by future generations, who will be genuinely agog that the evidence has been ignored for so long, that genuine concerns were disregarded, and that those raising them were gaslit, smeared and vilified.” ~ MP Andrew Bridgen

A whistleblower who leaked COVID shot mortality data in New Zealand, which has been described as a “vaccine massacre,” has revealed that 400 deaths were linked to one vaccinator and the Maori were especially targeted.  His home was raided and he was initially arrested but finally released. While average people were forced to take the shots in NZ, 11,000 “vaccine” exemptions were reserved for the elites, politicians and media propagandists.  

Now, journalist, Liz Gunn and leader of the NZ Loyal Party has been targeted by the New Zealand Employee Relations Authority. She received a letter from a lawyer to take down whistleblower Barry Young‘s content about the COVID injuries and deaths or go to jail for months, face a 40K fine, and face a police raid where they will confiscate her equipment.  Scroll to the 5 Min mark to hear about Young’s details including the fact he will be in the Wellington District Court on April 23.   

She warns that she is the ‘canary in the coal-mine,’ and represents what is going to happen to everyone in New Zealand.  I would add – for the rest of the world if we don’t stand up & refuse.

The government has shut down the NZ Loyal Party’s bank account that she is a part of, and has required extensive amounts of paperwork stretching the already small voluntary staff.

The persecution continues.

Mistakes were not made. Don’t let them get away with it.

Category:

Activism, vaccines, Viruses

Comments Off on Leaked Dossier Shows German Government Conspired to Silence Reiner Fuëllmich

Another Study: Human-Caused Carbon Emissions Have No Discernible Effect on Climate

https://www.naturalnews.com/2024-04-16-carbon-emissions-no-discernible-effect-climate-study

Human-caused carbon emissions have no discernible effect on climate, study finds

04/16/2024 // Ethan Huff
Despite lots of very loud and very influential people claiming otherwise, the so-called  “carbon emissions” caused by humans is “non-discernible,” to quote a prominent researcher, when it comes to having an impact on the climate.

Demetris Koutsoyiannis, a professor in Greece, published a paper recently that explains using scientific data how the expansion of a more productive biosphere is responsible for increased carbon dioxide (CO2) concentrations in the atmosphere, which have thus created a “greening” effect on the earth.

While the official story is that most, if not all, of the recent alleged planetary “warming” is caused by the four percent human contribution of burning hydrocarbons, Koutsoyiannis says this is nonsense, according to actual science.

There is no “climate emergency,” nor are humans responsible for destroying the earth with industry. While certain elements of industry could certainly be cleaned up to produce less pollution, the idea that human activity is causing the planet to boil to death is simply ludicrous.  (See link for article & study)

________________

**Comment**

Virtually every study on Lyme disease and ticks now has the ‘climate change’ narrative embedded within.  This is important to note and refute.  According to independent research, ticks are highly ecoadaptive and simply go under leaf litter or snow to survive another day.  They also have an anti-freeze type substance in them that allows them to survive harsh conditions.

For more:

The real problem?  Climate engineering.

For more on that:

Category:

Activism, Climate, Lyme, research, Ticks

Comments Off on Another Study: Human-Caused Carbon Emissions Have No Discernible Effect on Climate

Pfizer – The Manufacturer of the New Lyme ‘Vaccine’

Before you blindly accept another product from Pfizer, take a few moments to learn about this company.

  • Recently, a government commissioned report showed that both the Moderna and Pfizer COVID gene therapy shots cause myocarditis.
  • Pfizer has been found guilty and confessed to misleading the public on the COVID shot.
  • Demonstrating clear conflicts of interest, the DOJ asked the court to toss a whistleblower lawsuit alleging Pfizer defrauded the U.S. government, which Pfizer also attempted to wiggle out of because it said the government was aware of the fraud.
  • Pfizer stands accused of falsifying data, blind trial failures, and awareness that at least one exec was aware that members of the company’s staff were ‘falsifying data.’
  • This is not the first time Pfizer has been guilty. It paid $2.3 BILLION in a 2009 settlement for safety violations, false medical claims, corruption, and bribery – the largest healthcare fraud settlement in the history of the U.S. DOJ.
  • Pfizer has been fined heavily in the past due to violating the law over an extensive period of time.
  • Pfizer has also paid the largest civil fraud settlement of $1 BILLION.
  • Another Pfizer whistleblower confirms the COVID shot is a bioweapon.
  • Scientists globally are concerned about the DNA contamination issue in the Pfizer shot.
  • Pfizer collaborated with German biotech company BioNTech for the COVID gene therapy injection, a company that had only ever previously done trials for cancer therapies, none of which ever made it to a large-scale phase 3 clinical trial and one of which prematurely ended for unknown reasons. A new preprint by Rubio-Casillas et al. in the International Journal of Biological Macromolecules asks ‘N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?‘  Turns out it is a friend of cancer.  Further, “substituting N1-methyl-pseudouridine for naturally occurring uridine is precisely the innovation at the heart of BioNTech’s mRNA platform, which is thus, in reality, a modRNA or modified RNA platform.”  In short, “adding 100 % of N1-methyl-pseudouridine (m1Ψ) to the mRNA vaccine in a melanoma model stimulated cancer growth and metastasis, while non-modified mRNA vaccines induced opposite results, thus suggesting that COVID-19 mRNA vaccines could aid cancer development.”
  • A leaked Pfizer indemnification agreement forces countries to put up sovereign assets, bank reserves, military bases, & embassy buildings as collateral for expected ‘vaccine’ injury lawsuits.
Does this sound like a company that should be trusted with anything?

https://dailysceptic.org/2024/04/09/how-could-biontech-purchase-a-factory-for-its-vaccine-before-the-drug-was-approved/

How Could BioNTech Purchase a Factory for its Vaccine Before the Drug Was Approved?

One of the many important and untold stories of the COVID-19 response involves, not surprisingly, the German company BioNTech…

By Robert Kogon April 9, 2024

Article Excerpts:

As at least my readers will know, BioNTech is the actual developer, owner and legal manufacturer of what is more commonly and misleadingly known as the ‘Pfizer’ COVID-19 vaccine. It is also the authorisation holder for almost all markets, including the EU, the U.K. and the U.S.  But circa 2020, the legal manufacturer of the drug had a big problem: having never previously brought any product to market, it did not have any manufacturing facilities.

The problem was solved by its purchase from Novartis of the somewhat infamous  Behringwerke or ‘Behring Works’ in Marburg. Not only was the facility the site of the eponymous Marburg virus outbreak in 1967, but during the Second World War, as a subsidiary of the IG Farben chemical trust, it had been used to manufacture experimental vaccines for testing on concentration camp inmates at Buchenwald. This human experimentation was at the very heart of the Nuremberg ‘Doctors’ Trial’, as can be seen here.  (See link for article)

______________

The author queries how BioNTech was able to complete acquisition and refitting of Behring Works in Marburg before the ‘vaccine’ was even approved.  Did they know something we didn’t?

https://www.dossier.today/p/pfizer-to-pay-0-in-taxes-despite

Pfizer to pay $0 in taxes, despite billions in income

Every year, Pfizer sends an army of lobbyists to Washington, D.C., seeking to manipulate the tax code to their benefit.

JORDAN SCHACHTEL
APR 15, 2024
Article Excerpts:
Despite bringing in $58 billion in revenue and billions in net income for 2023, Pfizer is not paying a dime in taxes. Thanks to their scale, size, and taxpayer-funded support system, Pfizer and its peers reap tax benefits that allow for the zeroing out of their tax burden. Such privileges are not afforded to Main Street businesses, highlighting an incredibly unequal tax code that benefits mega corporations at the expense of the average citizen and small businesses.
The mRNA shots, coupled with the failed Paxlovid oral pill, gave Pfizer an unprecedented windfall, delivering tens of billions in annual profits.
For many years, Pfizer — like many of its Fortune 100 peers — has offshored virtually all of its profits, effectively zeroing out its tax burden.
And every year, Pfizer alone spends tens of millions of dollars lobbying legislators to manipulate the tax code to their benefit.  (See link for article)
  • Go here for “Pfizer’s Tax Dodging Rx: Stash Profits Offshore”
  • Go here to learn of the 2015 partnership Pfizer made with Israeli Bar Ilad University Research and Development Company Ltd. (BIRAD) managed by Prof. Ido Bachelet for programmable nanorobots that are injected into humans, issuing them an IP address and connecting them to the internet to be controlled remotely using magnetic fields.  They can be directed to a specific part of the body and then activated with a push of a button.

“No, no it’s not science fiction; it’s already happening.” ~  Ido Bachelet

  • Bachelet admits a treatment in mammals must overcome the immune response triggered when a foreign object enters the body.
  • It is also known that nanorobots are capable of molecular level destruction of the human body which could be used in bioterrorism to torture an opponent.
  • There is also a privacy issue due to the lack of informed consent and ‘snooping’ for surveillance purposes, as well as the issue of who controls it (insiders vs outsiders) and the fact it can’t be seen.
  • Nobody has a clue what this tech does to the environment.
  • Go here for a map of nanotech global catastrophic risks.
  • Go here to learn how the super computer CERN teamed up with cloud vendor Rackspace to build a “hybrid cloud” which uses a mix of servers and storage accessed all over the internet to handle an enormous amount of data.  The question to ask here is what for?  Here’s a few frightening ideas:
  • The simulation of nanostructured materials requires high performance computers and modern calculation methods. CERN makes this happen due to its ability to handle Big Data.
  • Go here for specific examples of how Pharma and U.S. Government agencies are bedfellows.
Pfizer is part and parcel of this global end-game.  Which should really make you question a Pfizer Lyme ‘vaccine.’

Patients question CDC about Pfizer Lyme vaccine–Part 2

By Lonnie Marcum

4/11/24

On March 6-7, 2024, I joined a group of other Lyme and tick-borne disease advocates meeting with members of the CDC and a representative from Pfizer in Atlanta.

Our goal was to develop a list of questions to help inform the Lyme vaccine program development and implementation if the Pfizer VLA15 Lyme vaccine (currently in phase 3 clinical trials) is approved for use in the U.S.

The advocates were invited in an effort to develop relationships that expand the CDC’s understanding of the lived experience of Lyme disease (from patients, caregivers and leadership from patient-driven research organizations).

From the beginning, I’ve aimed to be as transparent as possible with the Lyme community. As I shared in detail here, it was an extremely valuable meeting where the group brought forth scores of questions for Pfizer.

It has taken some time for the final list of questions to be compiled and reviewed by each of the participants. Below are the finalized questions as submitted to Pfizer today.

Setting the stage

This comprehensive list sets the stage for future communications with the CDC regarding any Lyme disease vaccines that may become available.

A special thanks goes out to Dr. Sue Visser of the CDC for coordinating the meeting and following through with all the details.

Also grateful to Dr. Lyle Petersen, Dr. Grace Marx and Dr. Paul Mead, CDC officials who stayed with us from start to finish. They listened to our personal stories and answered many technical questions.

From left: Lonnie Marcum, Olivia Goodreau, Bruce Fries, Holiday Goodreau, Wendy Adams, Bonnie Crater. Not shown: Pat Smith, who attended remotely.

And of course a HUGE shout-out to the other advocates in attendance: Wendy Adams, Bonnie Crater, Bruce Fries, Holiday Goodreau, Olivia Goodreau and Patricia Smith. (Click links to find out more about them.)

I sincerely hope we can get these questions answered. I will keep you informed as I learn more information from the CDC or Pfizer.

Questions for Pfizer

General Questions

  • Why didn’t Pfizer engage the Lyme disease community sooner in the vaccine development process?
  • Can you tell us why a presentati­on about VLA15 wasn’t provided by Pfizer for this meeting?
  • Is there a way to have access to presentati­ons previously given at scien­tific conferences (e.g., the Gordon Conference)?
  • Would Pfizer be able to make a presentati­on about VLA15 and the results of the clinical trials at a meeti­ng convened by CDC with a broad group of researchers and non-researchers from the Lyme community?

Questions About Vaccine Development

  • Which OspA fragments were used in VLA15?
  • Does the ST1-OspA that was used cover the strains in California?
  • How was OspA modified to prevent autoimmune reac­tivity to HLA/LFA?
  • What are the vaccine technology and ingredients? (Background note: there are concerns about the danger of those with alpha-gal receiving mammalian products via healthcare products.)
  • Why was OspA chosen as the target, given the LYMERix® concerns?
  • How is this vaccine similar and different than LYMERix®?
  • Specifically, how have the vaccine’s developers edited out the putati­ve mimic of hLFA-1? Is there any data to confirm that addi­tional epitopes are not problemati­c, if the mimic of hLFA-1 is not the only one that caused an autoimmune reacti­on in LymeRix? What data convinced you that VLA15 would be safer than LYMERix®?
  • Did Pfizer investi­gate any of the peer-reviewed ar­ticles on the problems that were thought to have affected those who took LYMERix® (for example, those related to HLA or demyelinati­on)?  If so, please provide a summary. If not, why?
  • What happened to the Baxter Lyme disease vaccine?  Did Pfizer look into this vaccine? Did Pfizer acquire any porti­on of the Baxter Lyme disease vaccine division?
  • What happened to the Connaught ImmuLyme vaccine? Did Pfizer look into this vaccine?
  • How does VLA15 prevent Lyme disease?
  • How long does it take for human anti­bodies to develop after the OspA vaccine? How long does this response conti­nue?
  • How long does it take for the anti­bodies in the human blood to deacti­vate the Borrelia in the ­tick (minutes, hours, days)?
  • What are the transmission assumpti­ons used in the development of VLA15?
  • Do you have plans for other ti­ckborne disease vaccines (e.g., babesiosis, bartonella, relapsing fever species)?
  • Do you keep a repository of trial samples for use in future research? If so, who can access them?
  • What are the greatest challenges Pfizer has faced in developing this vaccine? What challenges do you anti­cipate facing in the future?
  • Is there anything you can tell us that wasn’t in the press releases?

Questions About the VLA15 Trials

  • On the April 2022 press release, can you please clarify whether the pediatric immunogenicity response was similar or different for 2 or 3 dose schedule?
  • Who conducts Phase 4 studies? Does Pfizer intend to conduct Phase 4 studies?
  • One of the press releases references “observer blind”. Is “observer blind” different from “double blind”?
  • Can you please clarify the calculus of going from 6,000 target par­ticipants to the final recruited total of 9,437 parti­cipants?
  • Were data from the 3,000 disconti­nued VALOR par­ticipants retained? If so, how will they be analyzed?
  • Does the VLA15 series need to start at a specific ti­me of year to opti­mize immunological response?
  • On what data did Pfizer base the ­timing of a 12-month booster? If you will target boosters before “peak season” (as referenced in the 12/4/23 press release), how will “peak season” be defined?
  • In the 2/4/22 press release, how was the “subset” of phase 2 parti­cipants selected for the booster study?
  • How many of the 9,437 parti­cipants were enrolled from the US? Europe? Canada?
  • How do we know that one booster is sufficient when the initi­al series required 3 vaccines?
  • What were the par­ticipant incenti­ves?
  • Would you conduct subgroup analyses of those who contracted COVID-19 during the study?
  • In the clinical trials, parti­cipants were either “Lyme naïve” or had “cleared past infecti­on.” What diagnosti­c method was used to determine a person’s Lyme status? Did you test for other infec­tions? What diagnosti­cs were run overall, across ­time?
  • What Lyme disease testi­ng method is being used to verify vaccine efficacy?
  • Do you have data on the safety and efficacy of this vaccine in people who are pregnant? Do you have data on people who became pregnant during the trial? If so, what did the data show?If there are resul­ting pregnancies, will those pregnancies be followed, and will any offspring born be followed over ­time especially for any Lyme cases (e.g., vaccine failures)? Will specimens be collected?
  • Did you enroll people who were known to have non-Lyme ­tickborne diseases? If so, can you do subgroup analyses of them?
  • Have you evaluated the safety and efficacy of VLA15 in immunocompromised pati­ents? If not, will you? How did you define “immunocompromised”?
  • Did you enroll people with non-communicable diseases that weren’t part of the exclusion criteria? Do you intend to do subgroup analyses of this popula­tion?
  • What is the threshold to determine protecti­on and how is this threshold determined? How long does protecti­on last?
  • How long after getting the 3rd dose does it take to be fully protected?
  • Are you par­tially protected after one or two doses? If so, how much?
  • How long are clinical trial parti­cipants being monitored? If so, how?
  • Are there any sex-based differences in the immunological response?
  • Is there any therapeuti­c value to VLA15?
  • Can you provide the GCP guidelines that were violated by Care Access, leading to the removal of this contractor?

Questions About Adverse Events and Side Effects

  • Can you assess the safety and efficacy of VLA15 in those who have ti­ckborne diseases? Do you have plans to conduct subgroup analyses?
  • What is the safety profile and what are the side effects of VLA15? What were the worst side effects?
  • Do you have any plans to evaluate the safety and efficacy of VLA15 in pati­ents with persistent Lyme disease?
  • Can you get VLA15 if you’re sick (e.g., have cold symptoms, etc.)?
  • Can this vaccine be co-administered with other vaccines? If not, what is the wait ­time?
  • Is there a plan to co-administer the Lyme vaccine with the fall vaccines (e.g., COVID, flu, etc.) in order to opti­mize ti­ming of efficacy?

Questions About Post-Licensure

  • Are there future studies planned if VLA15 if licensed in the U.S, post-licensure (e.g., with those excluded from VALOR: pregnant people, breastfeeding people, elderly people)?
  • Are there plans to expand clinical trials to other regions of the world?
  • Where is/will VLA15 be manufactured?
  • What will the cost be? Will it be covered by insurance? If so, under what circumstances?
  • If recommenda­tions from ACIP are restricti­ve to geography, will Pfizer conduct additi­onal studies or trials to establish use in other geographic areas to support broader uptake?
  • What are the logisti­cs around vaccine implementati­on (shelf life, storage requirements, etc.)?
  • Are there anti­cipated impacts of VLA15 on subsequent diagnosti­c testi­ng for future infecti­ons (e.g., false positi­ves for Lyme disease, etc.)?
  • Will Pfizer enlist patient access programs to support uptake and accessibility to the vaccine?

Questions about Communications and Rollout

  • When can the public have access to the marke­ting plan described in one of the VLA15 press releases?
  • How will Pfizer ensure that the public understands the scope of protecti­on from VLA15, and specifically that it will not protect the public from ­tickborne diseases other than Lyme disease?

Questions for CDC

General Questions

  • Would Pfizer be able to convene a meeting at which the VLA clinical trial findings could be presented to the broad research and non-research Lyme community?

Questions About Adverse Events and Side Effects

  • When a person reports to VAERS, is their report/symptom placed into a coding system (used by the FDA or others), or are their symptoms investigated and analyzed at face value? [VAERS  stands for Vaccine Adverse Event Reporting System]
  • What is the reporting and investigation process of VAERS?
  • Do we currently (during the phase 3 clinical trial) have public access to adverse event data from the clinical trials (through VAERS or otherwise)? Does VAERS receive reports pre-licensure? If so, how are VAERS reports considered by FDA for licensure?]

Questions About Post-Licensure

  • What can be shared publicly about the ACIP member vetting process?
  • What is the conflict of interest process for vetting ACIP members?
  • If a person is shown to have a conflict of interest, is there a process to remove them? Is this information disclosed?
    Will VLA15 be considered for the Vaccines for Children program?
  • Would special populations get recommendations in the future, even if they were not included in the clinical trials?
  • Do states have an independent role in determining if a vaccine is included in the Vaccines for Children program?

Questions about Communications and Rollout

  • What are CDC’s plans for vaccine rollout, including website content?
  • How will CDC incorporate information about vaccine safety monitoring systems in its vaccine rollout?

Questions for FDA

Questions About the VLA15 Trial

  • Does FDA have a statement on why Pfizer discontinued a large number of participants in their US VALOR study?
  • Why did FDA clear Care Access (contractor)?
  • Why were FDA’s findings different than Pfizer’s?
  • If VAERS receives reports pre-licensure, how are these reports considered by FDA for licensure?

Questions for Department of Defense (DoD)

Questions About Post-Licensure

  • What is the vaccine recommendation process for DoD?

LymeSci is written by Lonnie Marcum, a physical therapist and mother of a daughter with Lyme. She served two terms on a subcommittee of the federal Tick-Borne Disease Working Group. Follow her on Twitter: @LonnieRhea  Email her at: lmarcum@lymedisease.org.

______________

**Comment**

It’s quite obvious that Pfizer has a lot to hide. There are more questions presented than answers.  The fact that Lyme advocates were handed press releases rather than real science should tell you everything you need to know.  Pfizer would happily make us wait 75 years to get ‘vaccine’ data if they can get away with it.

It is clear Pfizer COVID shot data was falsified, their internal emails tried to cover up inconvenient fetal cell usage, the experimental gene therapy injections increase COVID and likely have negative efficacy, can cause an inflammatory syndrome, have utterly and hopelessly flopped, and are linked to more reports adverse reactions and death than any other vaccine in the history of VAERS, which only has a 1% capture rate.

Pfizer also quietly financed groups lobbying for ‘vaccine’ mandates and Pfizer colludes with the NIH through the Bayh-Dole Act and it’s NIH royalty-sharing agreement.

Are you seriously going to trust this company with a Lyme ‘vaccine?’

Go here for part 1.

Category:

Activism, vaccines, Viruses

Comments Off on Pfizer – The Manufacturer of the New Lyme ‘Vaccine’

Marshfield Clinic Research Institute Seeks Residents to Collect Ticks

April 19, 2024

https://wausaupilotandreview.com/2024/04/09/marshfield-clinic-research-institute-seeks-residents-to-collect-ticks/

Marshfield Clinic Research Institute seeks residents to collect ticks

by Shereen Siewert

Ticks might be one of people’s least favorite creatures. If you find a tick on yourself or your pet, the first reaction may be to squish it or flush it down the toilet, but that tick could help researchers learn more about the parasitic arachnid and its potential to carry disease.

Scientists at Marshfield Clinic Research Institute are asking the public to submit ticks for a research study called Tick Inventory via Citizen Science. The study is surveying the distribution of tick species in our area, including any new, invasive ticks that could be moving into Wisconsin. They will also identify the microbes carried by each tick, including pathogens that may cause diseases, such as Lyme disease, anaplasmosis, and babesiosis, and non-pathogenic microbes that could contribute to a tick’s likelihood of carrying disease.

“Ticks are moving into new areas as the environment changes,” said Alexanda Linz, MCRI associate research scientist. “This is an opportunity for Wisconsinites to act as citizen scientists and help us learn about ticks and their diseases, which can potentially help us better inform on disease prevention and early detection as well as develop improved diagnostic tools and treatments.”

The first phase of this survey is targeting the Marshfield area. For more information or to request a kit, contact tics@marshfieldclinic.org, 715-389-7796, extension 16462. Ticks can also be submitted by picking up a pre-paid collection kit from:

  • Stanton W. Mead Education and Visitor Center at Mead Wildlife, S2148 Highway S, Milladore
  • Castlerock Veterinary Hospital, 1214 S. Oak Ave., Marshfield
  • Rib Mountain State Park, 149801 State Park Road, Rib Mountain  (See link for article)

________________

**Comment**

See link for directions on how to send the tick in.  They will expand this to other areas of Wisconsin later this summer with collection kits at parks, hiking trails, and veterinary clinics.

Category:

Activism, research, Ticks

Comments Off on Marshfield Clinic Research Institute Seeks Residents to Collect Ticks